Indeed, the use of pioglitazone, a peroxisome proliferator activated receptor-γ (PPAR-γ) agonist known to increase LRP1 in the brain, significantly ameliorated the learning and memory impairment in AD transgenic mice by upregulating neuronal LRP1 expression in hippocampal neurons [50]. This evidence concerns the gene PPARG and Alzheimer disease.